ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LPCN vs BIVI // ENTERPRISE SCALE & MARKET CAP

Lipocine Inc. (NASDAQ) VS. BioVie Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: LPCN 1 — BIVI 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: LPCN
market-cap
$12.0M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LPCN VS. BIVI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LPCN BIVI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 BIVI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.9 47.8 -12.90 BIVI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $12.0M $11.9M $58.9K LPCN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LPCN REV BIVI REV LPCN GROSS % BIVI GROSS % LPCN FCF BIVI FCF
FY 2025 $2.0M $50.6M — — -$9.8M -$19.0M
FY 2024 $11.2M $90.1M — — -$1.3M -$27.9M
FY 2023 -$2.9M $126.2M — — -$11.9M -$40.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LPCN // BETA —
BIVI // BETA —